Among these, the skin whitening & aesthetic treatments segment dominated the market in 2025 and is expected to maintain strong growth throughout the forecast period
We are dedicated to offering our patients science-backed, innovative solutions to support their weight loss and overall wellness journeys
GLP1 weight loss support Behavioural support while taking GLP1 medication Mounjaro, Wegovy and Menopause Belly Fat One of the most common concerns during menopause is increased abdominal or belly fat
No, GLP-1 receptor agonists are not MHRA-approved for dementia or cognitive decline
If you are in the Los Angeles or Orange County area, please contact us, and we can get you the help you need
Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE)